CARIS LIFE SCIENCES

In News

Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan - PR Newswire

PR Newswire - Jan 28, 2026

Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 - BioSpace

BioSpace - Feb 10, 2026

Caris Life Sciences Insiders Placed Bullish Bets Worth US$897.8k - Yahoo Finance

Yahoo Finance - Feb 08, 2026

FMR LLC's Strategic Acquisition in Caris Life Sciences Inc. - GuruFocus

GuruFocus - Feb 12, 2026

Caris Life Sciences stock holds steady as Canaccord maintains $30 target - Investing.com

Investing.com - Jan 26, 2026

Matthew Oberley: Caris Life Sciences Unveils AI Driven Breast Cancer Recurrence Risk Project at SABCS 25 - Oncodaily

Oncodaily - Dec 11, 2025

North Texas' Caris Life Sciences To Collaborate With Genentech on Novel Therapeutic Targets for Cancers - Dallas Innovates

Dallas Innovates - Dec 17, 2025

December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B - Fierce Biotech

Fierce Biotech - Dec 16, 2025

Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results - PR Newswire

PR Newswire - Jan 12, 2026

Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need - PR Newswire

PR Newswire - Dec 16, 2025

ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification - PR Newswire

PR Newswire - Dec 10, 2025

Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 - PR Newswire

PR Newswire - Oct 14, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment